PSA diagnostic case studies

Dr Sam Merriel and Dr Olly Hulson cover some case studies common to Primary Care, to explore early diagnosis and diagnostic pathways through real-world scenarios.
Tens of thousands fewer men face harm in prostate cancer diagnosis
Prostate Cancer UK’s new research indicates that improved scans and safer biopsies may allow the UK to launch a prostate cancer screening program, potentially reducing deaths and harms, with the National Screening Committee considering new screening proposals.
The professional development framework for specialist prostate cancer nursing
This Professional Development Framework, supported by Prostate Cancer UK and developed by nurses, researchers, and patients, outlines the essential skills, knowledge, and training for nurses advancing in prostate cancer care.
Prostate Cancer Essentials: Part 2 – Diagnosing and Staging

A course providing healthcare professionals with an increased understanding of how prostate cancer is diagnosed.
The modern prostate cancer diagnostic pathway

Dr. Olly Hulson provides an overview of the modern prostate cancer diagnostic pathway.
PSA consensus recommendations and implications for practice

Dr. Sam Merriel presents PSA consensus recommendations and implications for practice.
Remote consultations: experiences of UK patients with prostate cancer during the COVID-19 pandemic
The article highlights that UK prostate cancer patients preferred in-person consultations for key discussions but accepted remote consultations for routine follow-ups, suggesting a balanced approach with critical decisions made face-to-face.
Prostate mpMRI in the UK: the state of the nation
The article discusses how advancements in multiparametric MRI (mpMRI) are enhancing prostate cancer diagnosis by reducing unnecessary biopsies and targeting significant cancers, despite ongoing challenges like geographical variation and limited resources.
Prostate Cancer Essentials: Part 1 – Introduction to Prostate Cancer

A course providing an introduction to the prostate and prostate cancer covering all of the essential information for healthcare professionals who have taken on a role supporting people affected by cancer.
Is the digital rectal exam any good as a prostate cancer screening test?
The article critiques the digital rectal examination (DRE) for prostate cancer screening, highlighting its limitations compared to multi-parametric MRI (mpMRI) and discussing emerging methods from the TRANSFORM trial to improve detection and reduce unnecessary procedures.